ESMO/X
Jun 26, 2025, 11:16
Elena Castro Discussed Positive Findings from the CAPTURE and AMPLITUDE trials in the ESMO Daily Reporter – ESMO
ESMO shared a post on LinkedIn:
“Positive findings from the CAPTURE and AMPLITUDE trials highlight the importance of Early Testing patients for BRCA and HRR mutations.
Read the opinion by Elena Castro in the ESMO Daily Reporter where she discusses how findings from both trials highlight the importance of identifying genetic alterations in metastatic hormone-sensitive prostate cancer (mHSPC) to tailor therapeutic options to our patients.”
Read Full Article on ESMO Daily Reporter.
More posts featuring ESMO on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20
Jun 26, 2025, 13:31